SorLA restricts TNFα release from microglia to shape a glioma-supportive brain microenvironment.
Paulina KaminskaPeter L OvesenMateusz JakielTomasz ObrebskiVanessa SchmidtMichal DraminskiAleksandra G BilskaMagdalena BieniekJasper AninkBohdan PaterczykAnne Mette Gissel JensenSylwia PiatekOlav M AndersenEleonora AronicaThomas E WillnowBozena KaminskaMichał J DąbrowskiAnna R MalikPublished in: EMBO reports (2024)
SorLA, encoded by the gene SORL1, is an intracellular sorting receptor of the VPS10P domain receptor gene family. Although SorLA is best recognized for its ability to shuttle target proteins between intracellular compartments in neurons, recent data suggest that also its microglial expression can be of high relevance for the pathogenesis of brain diseases, including glioblastoma (GBM). Here, we interrogated the impact of SorLA on the functional properties of glioma-associated microglia and macrophages (GAMs). In the GBM microenvironment, GAMs are re-programmed and lose the ability to elicit anti-tumor responses. Instead, they acquire a glioma-supporting phenotype, which is a key mechanism promoting glioma progression. Our re-analysis of published scRNA-seq data from GBM patients revealed that functional phenotypes of GAMs are linked to the level of SORL1 expression, which was further confirmed using in vitro models. Moreover, we demonstrate that SorLA restrains secretion of TNFα from microglia to restrict the inflammatory potential of these cells. Finally, we show that loss of SorLA exacerbates the pro-inflammatory response of microglia in the murine model of glioma and suppresses tumor growth.
Keyphrases
- inflammatory response
- neuropathic pain
- lps induced
- lipopolysaccharide induced
- poor prognosis
- toll like receptor
- end stage renal disease
- rheumatoid arthritis
- spinal cord
- induced apoptosis
- genome wide
- ejection fraction
- white matter
- resting state
- chronic kidney disease
- signaling pathway
- single cell
- newly diagnosed
- peritoneal dialysis
- prognostic factors
- randomized controlled trial
- big data
- reactive oxygen species
- cell cycle arrest
- spinal cord injury
- gene expression
- functional connectivity
- cerebral ischemia
- cell proliferation
- endoplasmic reticulum stress
- risk assessment